NaturemiRI, LLC has competed pre-clinical trails in mice, rats and dogs validating the role of the PMIS Inhibitor System in tissue and bone regeneration, inhibition of periodontal disease, inhibition of colon cancer and thyroid development.

NaturemiRI Team has obtained over $2.7M in NIH funding, $225K in Economic funding and is currently seeking New Investors.

Human phase I clinical trials are in preparation.

The NaturemiRI team presents many invited talks at International and National meetings each year, please stop by and we would be happy to discuss our system and applications.